Loading clinical trials...
Loading clinical trials...
Combined Use of Dexmedetomidine and Hydrocortisone to Prevent New Onset Atrial Fibrillation After Coronary Artery Bypass Grafting Surgery
Conditions
Interventions
Dexmedetomidine + Hydrocortisone
Locations
1
Egypt
Cardiothoracic Academy, Ain Shams University Hospitals
Cairo, Egypt
Start Date
December 25, 2022
Primary Completion Date
June 25, 2023
Completion Date
July 25, 2023
Last Updated
January 10, 2023
NCT04528511
NCT05287191
NCT03866148
NCT05780320
NCT04870424
NCT06793319
Lead Sponsor
Ain Shams University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions